查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗病毒藥物市場，按類型、按應用、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1408902

抗病毒藥物市場，按類型、按應用、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Antiviral Drugs Market, By Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年抗病毒藥物市場規模為684.304億美元，2023年至2030年複合CAGR為-2.1%。

抗病毒藥物市場-市場動態

病毒性疾病的流行和抗病毒藥物的開發將推動市場需求

在預測期內，人們對不同病毒感染疫苗的認知和可用性不斷提高，以及病毒性疾病盛行率的上升，導致學名藥的推出，預計將對市場的成長產生積極影響。世界衛生組織估計，全世界有 3.25 億人患有肝炎感染，其中約 7,100 萬人患有C型肝炎病毒 (HCV) 慢性感染。此外，美國衛生與公共服務部計算出，全國有85萬人感染B型肝炎，240萬人感染C型肝炎。因此，預期隨著病患數量的增加，國際上抗病毒藥物的需求將會上升成長。

抗病毒藥物市場-關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 -2.1% 左右的CAGR成長
  • 根據類型細分，由於品牌療法在病毒治療中的廣泛採用，預計合成品牌細分市場將在 2022 年顯示最大的市場佔有率。
  • 根據應用細分，HIV 細分市場是 2022 年的主導類型，主要是由於抗逆轉錄病毒治療藥物的需求不斷增加。
  • 從配銷通路細分來看，醫院藥房是2022年的主導類型，主要是由於住院治療需求。
  • 按地區分類，由於擁有技術先進的生產設施，北美將成為 2022 年的主要收入來源。

抗病毒藥物市場-細分分析：

  • 全球抗病毒藥物市場根據類型、應用、配銷通路和地區進行細分。
  • 市場依類型分為四大類：品牌和學名藥。品牌區隔市場佔據主導地位。科技的發展以及對新型療法的日益重視可能會促進市場的成長。
  • 根據應用，市場分為五類：愛滋病毒、肝炎、皰疹、流感等。 HIV 細分市場在市場上佔據主導地位，並可能在預測期內保持其主導地位。抗病毒藥物在治療藥物治療愛滋病毒感染中發揮著至關重要的作用。
  • 根據配銷通路，市場分為三類：醫院藥房、零售藥房和網路藥房。醫院藥房在市場上佔據主導地位，並可能在預測期內保持其主導地位。憑藉線上電子商務的優勢，線上藥局正在快速獲得更多關注。

抗病毒藥物市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

抗病毒藥物市場-競爭格局：

為了增加市場佔有率，企業正在採取合資、合併、收購、臨床試驗和策略協議等策略性舉措，以擴大其產品線。行業參與者也關注針對食物過敏的產品發布和全球擴張，以保持其在全球市場的地位。全球抗病毒藥物市場受到 FDA、美國和政府合作的支持進一步影響。例如，2021 年 12 月，默克與 Ridgeback Biotherapeutics 合作，FDA 批准了 molnupiravir，一種口服抗病毒藥物，用於治療從低到高的 COVID-19。

最近的發展：

2022 年 3 月，研究技術和藥物發現組織 Scripps Research 與艾伯維公司 (AbbVie Inc.) 建立了戰略合作關係，以研究新藥，為 COVID-19 提供即時治療。

目錄

第1章：抗病毒藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的抗病毒藥物市場片段
    • 抗病毒藥物市場片段（按應用）
    • 按配銷通路分類的抗病毒藥物市場片段
    • 按國家/地區分類的抗病毒藥物市場片段
    • 按地區分類的抗病毒藥物市場片段
  • 競爭洞察

第 3 章：抗病毒藥物主要市場趨勢

  • 抗病毒藥物市場促進因素
    • 市場促進因素的影響分析
  • 抗病毒藥物市場限制
    • 市場限制影響分析
  • 抗病毒藥物市場機會
  • 抗病毒藥物市場未來趨勢

第 4 章：抗病毒藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：抗病毒藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：抗病毒藥物市場格局

  • 2022 年抗病毒藥物市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：抗病毒藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 品牌化
    • 泛型

第 8 章：抗病毒藥物市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 愛滋病
    • 肝炎
    • 皰疹
    • 流感
    • 其他

第 9 章：抗病毒藥物市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第 10 章：抗病毒藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美抗病毒藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲抗病毒藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區抗病毒藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲抗病毒藥物主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲抗病毒藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-抗病毒藥物產業

  • 競爭儀表板
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • GSK plc.
    • AbbVie, Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson Services, Inc.
    • Bristol-Myers Squibb Company
    • Cipla Inc.
    • Ridgeback Biotherapeutics
    • Aurobindo Pharm
    • Dr. Reddy's Laboratories Ltd.
    • Zydus Pharmaceuticals
    • SIGA Technologies
    • Pfizer Inc.
    • NAVINTA LLC
    • Sun Pharma
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2084

REPORT HIGHLIGHT

Antiviral Drugs Market size was valued at USD 68,430.4 Million in 2022, expanding at a CAGR of -2.1% from 2023 to 2030.

Antiviral drugs are prescriptions that work by preventing viruses from replicating within the cells that they infect. These medications either stop the virus from entering the host cell or disrupt essential enzymes or proteins needed for viral reproduction. They are designed to target certain viruses or virus species.

Antiviral Drugs Market- Market Dynamics

Increasing prevalence of viral disorders and development in antiviral medicines is to propel market demand

Over the forecast period, rising awareness and availability of different vaccinations for viral infections and the rising prevalence of viral diseases, which has led to the launch of generic versions of antiviral medications, are projected to positively affect the market's growth. The WHO estimates that 325 million individuals worldwide have hepatitis infection, and of those, about 71 million have chronic infection with the Hepatitis C virus (HCV). Furthermore, the U.S. Department of Health and Human Services calculated that 850,000 people in the nation are infected with hepatitis B, and 2.4 million people with hepatitis C. Therefore, it is expected that the demand for antiviral medications will rise internationally as the number of patients grows.

Antiviral Drugs Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around -2.1% over the forecast period (2023-2030)
  • Based on Type segmentation, synthetic branded segment was predicted to show maximum market share in the year 2022, owing to high adoption of branded therapeutics in viral treatment.
  • Based on Application segmentation, HIV segment was the leading type in 2022, mainly due to increasing demand for antiretroviral therapy medications.
  • Based on Distribution Channel segmentation, hospital pharmacy was the leading type in 2022, mainly due to hospitalization treatment needs.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to availability of technologically advanced production facilities.

Antiviral Drugs Market- Segmentation Analysis:

  • The Global Antiviral Drugs Market is segmented on the basis of Type, Application, Distribution Channel, and Region.
  • The market is divided into four categories based on Type: branded and generics. The branded segment dominates the market. The technology development, growing emphasis on novel therapeutics are likely to contribute to market growth.
  • The market is divided into five categories based on Application: HIV, hepatitis, herpes, influenza, and others. The HIV segment dominates the market and is likely to maintain its dominance during the forecast period. Antiviral drugs play crucial role in treatment of HIV viral infections with therapeutic medications.
  • The market is divided into three categories based on Distribution Channel: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy dominates the market and is likely to maintain its dominance during the forecast period. Online pharmacy is gaining more traction at fast pace with online e-commerce benefits.

Antiviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antiviral Drugs Market- Competitive Landscape:

To increase their market share, businesses are engaging in strategic initiatives like joint ventures, mergers, acquisitions, clinical trials, and strategic agreements for the purpose of expanding their product line. Industry participants are also focusing on product releases for food allergies and global expansion to maintain their position in the global market. The worldwide antiviral drugs market has been further impacted by supportive FDA, U.S., and government collaborations. For instance, in December 2021, Merck collaborated with Ridgeback Biotherapeutics and established FDA approval for molnupiravir, an oral antiviral agent for backup use to treat low to high COVID-19.

Recent Developments:

In March 2022, Scripps Research, a research & technology and drug discovery organization, and AbbVie Inc. established a strategic collaboration to investigate novel drugs, to provide immediate treatments for COVID-19.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIVIRAL DRUGS MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd.
  • GSK plc.
  • AbbVie, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Ridgeback Biotherapeutics
  • Aurobindo Pharm
  • Dr. Reddy's Laboratories Ltd.
  • Zydus Pharmaceuticals
  • SIGA Technologies
  • Pfizer Inc.
  • NAVINTA LLC
  • Sun Pharma
  • Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY TYPE

  • Branded
  • Generics

GLOBAL ANTIVIRAL DRUGS MARKET, BY APPLICATION

  • HIV
  • Hepatitis
  • Herpes
  • Influenza
  • Others

GLOBAL ANTIVIRAL DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL ANTIVIRAL DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antiviral Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antiviral Drugs Market Snippet by Type
    • 2.1.2. Antiviral Drugs Market Snippet by Application
    • 2.1.3. Antiviral Drugs Market Snippet by Distribution Channel
    • 2.1.4. Antiviral Drugs Market Snippet by Country
    • 2.1.5. Antiviral Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Antiviral Drugs Key Market Trends

  • 3.1. Antiviral Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antiviral Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antiviral Drugs Market Opportunities
  • 3.4. Antiviral Drugs Market Future Trends

4. Antiviral Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antiviral Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antiviral Drugs Market Landscape

  • 6.1. Antiviral Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antiviral Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Branded
    • 7.1.3. Generics

8. Antiviral Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. HIV
    • 8.1.3. Hepatitis
    • 8.1.4. Herpes
    • 8.1.5. Influenza
    • 8.1.6. Others

9. Antiviral Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies

10. Antiviral Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Antiviral Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Antiviral Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Antiviral Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Antiviral Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Antiviral Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antiviral Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. GSK plc.
    • 11.2.3. AbbVie, Inc.
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Johnson & Johnson Services, Inc.
    • 11.2.6. Bristol-Myers Squibb Company
    • 11.2.7. Cipla Inc.
    • 11.2.8. Ridgeback Biotherapeutics
    • 11.2.9. Aurobindo Pharm
    • 11.2.10. Dr. Reddy's Laboratories Ltd.
    • 11.2.11. Zydus Pharmaceuticals
    • 11.2.12. SIGA Technologies
    • 11.2.13. Pfizer Inc.
    • 11.2.14. NAVINTA LLC
    • 11.2.15. Sun Pharma
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antiviral Drugs Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Antiviral Drugs Market, by Type 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Antiviral Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Antiviral Drugs Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Antiviral Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antiviral Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antiviral Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antiviral Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antiviral Drugs Market share and leading players, 2022
  • FIGURE Europe Antiviral Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Antiviral Drugs Market share and leading players, 2022
  • FIGURE Latin America Antiviral Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Antiviral Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Germany Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antiviral Drugs Market share analysis by country, 2022
  • FIGURE India Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Brazil Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antiviral Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antiviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)